Interestingly, cystometric recordings from TREK-1 KO mice revealed a significant increase in the duration of inter-micturition interval, also expressed enhanced bladder capacity and increased number of nonvoiding contractions in comparison to WT mice. CONCLUSIONS: Our data suggest that the knockout of TREK-1 channels has dual effects on detrusor contractility and micturition patterns, most likely due to expression of TREK-1 channels on both smooth muscle and neuronal cells. METHODS: Twenty female SHRs were randomized to receive a four-week course of prazosin (0.12 mg/kg/day) or vehicle, and ten female Wistar-Kyoto (WKY) rats were given vehicle. Prazosin or vehicle was administered with an osmotic pump. The effect of this agent on urodynamic parameters was determined by continuous cystometry in conscious animals. After cystometry, c-Fos expression in the dorsal horn of the L6 spinal cord was measured by immunohistochemistry.
INTRODUCTION AND OBJECTIVES:
This study investigated the effects of long-term administration of the ?1-adrenoceptor antagonist, prazosin, on afferent inputs from the lower urinary tract (LUT) by evaluating c-Fos expression in the spinal cord of a spontaneously hypertensive rat (SHR) model of autonomic nervous system overactivity.
METHODS: Twenty female SHRs were randomized to receive a four-week course of prazosin (0.12 mg/kg/day) or vehicle, and ten female Wistar-Kyoto (WKY) rats were given vehicle. Prazosin or vehicle was administered with an osmotic pump. The effect of this agent on urodynamic parameters was determined by continuous cystometry in conscious animals. After cystometry, c-Fos expression in the dorsal horn of the L6 spinal cord was measured by immunohistochemistry.
RESULTS: Cystometric evaluation showed that the bladder contraction interval was significantly shorter and that cystometric capacity was significantly decreased in SHRs when compared with WKY rats (table). Moreover, L6 spinal cord c-Fos expression was significantly greater in SHRs than in WKY rats (figure).Administration of prazosin significantly increased micturition interval and bladder capacity, but did not affect micturition pressure or residual urine volume (table) . In SHRs, the number of c-Fos-positive neurons in the dorsal horn was significantly lower in response to prazosin than in response to vehicle (figure).
CONCLUSIONS: Increased afferent input from the LUT may induce an increase in urinary frequency in SHRs. Furthermore, longterm administration of prazosin at clinically recommended doses can exert inhibitory effects on afferent pathways from the LUT during the storage phase. Reductions of afferent input can result in increased bladder capacity and increased micturition interval. 
BOO). Using next generation sequencing (NGS) of mRNAs and miRNAs in human patients
0 biopsies and cell based systems we identified and validated TNF-a as the top upstream regulator of signaling in obstructed bladders. In the patients 0 biopsies, the up-regulated targets of the inhibited miRNAs contributed to the majority of activated signaling pathways. Here we sought to investigate the specific contribution of TNF-a-induced and -inhibited miRNAs to aberrant signaling in the smooth muscle cells (SMC), leading to cell proliferation and bladder fibrosis.
METHODS: SMC cells were treated with TNF-a and RNA isolated. Transcriptome analysis performed by NGS, NanoString nCounter miRNA assays were used to profile miRNAs. miRNAs and anti-miRs were expressed in SMCs using lentiviral vectors. NFkB-luciferase assays were performed to determine the effect of miRNAs on TNF-a signaling.
RESULTS: Compensatory overexpression of SM-specific, TNFa-inhibited miR-199a-5p significantly reduced NFkB-driven luciferase gene expression via down-regulation of its direct targets IKKB, MAP3K5, NFKB1 and PIK3CD. siRNA-mediated knockdown of IKKB or MAP3K5 mimicked the effect of miR-199a-5p. Transcriptome analysis of TNF-treated cells showed that 629 targets of 15 down-regulated miRs were up-regulated, whereas only 352 targets of 13 elevated miRs were decreased, indicating the higher impact of down-regulated miRNAs. 269 elevated mRNA targets of down-regulated miRNAs were implicated in regulation of 80% TNF-induced pathways. Top pathway elements were targeted specifically by miR-199a-5p, miR-424-5p and miR-149-5p. These miRNAs are reduced in BOO patients' biopsies, making them candidates for therapeutic intervention.
CONCLUSIONS: Compensatory up-regulation of miR-199a-5p and other miRNAs, inhibited by TNF-a might have a beneficial effect by reducing the proliferative and fibrotic changes in BOO bladders. The importance of the targets of down-regulated miRNAs for signaling might mean that the therapeutic efforts should concentrate on finding the pharmacological ways to enhance their expression to counter-balance fibrotic bladder remodeling.
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